MYC and cancer: Enhanced MYC levels in tumors induce the “squelching” of SPT5, subtracting this and other components of elongation machinery from genes that are known targets of MYC-dependent repression, such as those encoding TGFβ pathway proteins and regulators of immune system in cancer.